Details for New Drug Application (NDA): 022501

✉ Email this page to a colleague

NDA 022501 describes LO LOESTRIN FE, which is a drug marketed by Apil and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug. Additional details are available on the LO LOESTRIN FE profile page.

The generic ingredient in LO LOESTRIN FE is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.

Summary for 022501

Tradename:	LO LOESTRIN FE
Applicant:	Apil
Ingredient:	ethinyl estradiol; norethindrone acetate
Patents:	1

Suppliers and Packaging for NDA: 022501

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
LO LOESTRIN FE	ethinyl estradiol; norethindrone acetate	TABLET;ORAL	022501	NDA	Allergan, Inc.	0430-0420	0430-0420-14	5 BLISTER PACK in 1 CARTON (0430-0420-14) / 1 KIT in 1 BLISTER PACK
LO LOESTRIN FE	ethinyl estradiol; norethindrone acetate	TABLET;ORAL	022501	NDA	Allergan, Inc.	0430-0420	0430-0420-60	8 CARTON in 1 TRAY (0430-0420-60) / 30 BLISTER PACK in 1 CARTON / 1 KIT in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	0.01MG,0.01MG;1MG,N/A
Approval Date:	Oct 21, 2010	TE:		RLD:	Yes
Patent:	7,704,984	Patent Expiration:	Feb 2, 2029	Product Flag?		Substance Flag?		Delist Request?
Patented Use:	LO LOESTRIN FE IS INDICATED FOR THE PREVENTION OF PREGNANCY IN WOMEN WHO ELECT TO USE ORAL CONTRACEPTIVES AS A METHOD OF CONTRACEPTION

Expired US Patents for NDA 022501

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Apil	LO LOESTRIN FE	ethinyl estradiol; norethindrone acetate	TABLET;ORAL	022501-001	Oct 21, 2010	5,552,394	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.